Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corcept Therapeutics (CORT) Raw Materials (2016 - 2024)

Historic Raw Materials for Corcept Therapeutics (CORT) over the last 6 years, with Q1 2024 value amounting to $704000.0.

  • Corcept Therapeutics' Raw Materials changed N/A to $704000.0 in Q1 2024 from the same period last year, while for Mar 2024 it was $704000.0, marking a year-over-year change of. This contributed to the annual value of $1.7 million for FY2020, which is 2131.03% up from last year.
  • Per Corcept Therapeutics' latest filing, its Raw Materials stood at $704000.0 for Q1 2024.
  • Corcept Therapeutics' 5-year Raw Materials high stood at $1.7 million for Q4 2020, and its period low was $704000.0 during Q1 2024.